Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-4-29
pubmed:abstractText
The aim of this study was to evaluate the possibility of soft-tissue augmentation adopting tissue engineering and regenerative medicine (TERM) technology for a longer duration of injected implants.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1477-2566
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
307-16
pubmed:meshHeading
pubmed-meshheading:19333802-Animals, pubmed-meshheading:19333802-Cells, Cultured, pubmed-meshheading:19333802-Collagen Type I, pubmed-meshheading:19333802-Fibroblasts, pubmed-meshheading:19333802-Humans, pubmed-meshheading:19333802-Hyaluronic Acid, pubmed-meshheading:19333802-Immunocompromised Host, pubmed-meshheading:19333802-Injections, Intradermal, pubmed-meshheading:19333802-Mesenchymal Stem Cell Transplantation, pubmed-meshheading:19333802-Mesenchymal Stem Cells, pubmed-meshheading:19333802-Microscopy, Fluorescence, pubmed-meshheading:19333802-Platelet-Rich Plasma, pubmed-meshheading:19333802-Rats, pubmed-meshheading:19333802-Rats, Inbred F344, pubmed-meshheading:19333802-Regenerative Medicine, pubmed-meshheading:19333802-Severe Combined Immunodeficiency, pubmed-meshheading:19333802-Tissue Engineering, pubmed-meshheading:19333802-Tissue Scaffolds
pubmed:year
2009
pubmed:articleTitle
Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds.
pubmed:affiliation
Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't